BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25238939)

  • 41. A comparative analysis of immunohistochemistry and fluorescent
    Wagle PB; Jambhekar NA; Kumar R; Prabhash K; Pramesh CS; Desai SB; Noronha V; Karimundackal G; Shah A; Joshi A; Laskar SG; Jiwnani S; Pai T; Agarwal JP
    Indian J Cancer; 2017; 54(1):148-154. PubMed ID: 29199679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
    Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
    Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement.
    Nakajima N; Yoshizawa A; Kondo K; Rokutan-Kurata M; Hirata M; Furuhata A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Fujimoto M; Date H; Haga H
    Histopathology; 2017 Jul; 71(1):143-149. PubMed ID: 28231386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma.
    Bulutay P; AkyÜrek N; MemiŞ L
    Turk Patoloji Derg; 2021; 37(1):7-17. PubMed ID: 32876329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
    Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y
    Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.
    Mescam-Mancini L; Lantuéjoul S; Moro-Sibilot D; Rouquette I; Souquet PJ; Audigier-Valette C; Sabourin JC; Decroisette C; Sakhri L; Brambilla E; McLeer-Florin A
    Lung Cancer; 2014 Feb; 83(2):168-73. PubMed ID: 24380695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.
    Takahashi T; Sonobe M; Kobayashi M; Yoshizawa A; Menju T; Nakayama E; Mino N; Iwakiri S; Sato K; Miyahara R; Okubo K; Manabe T; Date H
    Ann Surg Oncol; 2010 Mar; 17(3):889-97. PubMed ID: 20183914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of EML4-ALK gene fusion mutation in patients 
with non-small cell lung cancer].
    Wang X; Chen W; Yu Y
    Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):80-4. PubMed ID: 25676400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EML4-ALK translocation in both metachronous second primary lung sarcomatoid carcinoma and lung adenocarcinoma: a case report.
    Alì G; Proietti A; Niccoli C; Pelliccioni S; Borrelli N; Giannini R; Lupi C; Valetto A; Bertini V; Lucchi M; Mussi A; Fontanini G
    Lung Cancer; 2013 Aug; 81(2):297-301. PubMed ID: 23664446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case of synchronous bilateral lung cancers: EML4-ALK positive adenocarcinoma in the right lung and adenocarcinoma in situ (the former bronchioloalveolar carcinoma) in the left lung.
    Matsuda I; Takeuchi K; Mizuguchi S; Kaji M; Ueda K; Teramura K; Hirota S
    BMC Pulm Med; 2013 Apr; 13():25. PubMed ID: 23617234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reliability Assurance of Detection of EML4-ALK Rearrangement in Non-Small Cell Lung Cancer: The Results of Proficiency Testing in China.
    Li Y; Zhang R; Peng R; Ding J; Han Y; Wang G; Zhang K; Lin G; Li J
    J Thorac Oncol; 2016 Jun; 11(6):924-9. PubMed ID: 26988569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
    Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
    Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR/Cas9 Technology-Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing.
    Peng R; Zhang R; Lin G; Yang X; Li Z; Zhang K; Zhang J; Li J
    J Mol Diagn; 2017 Sep; 19(5):766-775. PubMed ID: 28732214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum carcinoembryonic antigen levels before initial treatment are associated with EGFR mutations and EML4- ALK fusion gene in lung adenocarcinoma patients.
    Wang WT; Li Y; Ma J; Chen XB; Qin JJ
    Asian Pac J Cancer Prev; 2014; 15(9):3927-32. PubMed ID: 24935562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel KIF5B-ALK variant in nonsmall cell lung cancer.
    Wong DW; Leung EL; Wong SK; Tin VP; Sihoe AD; Cheng LC; Au JS; Chung LP; Wong MP
    Cancer; 2011 Jun; 117(12):2709-18. PubMed ID: 21656749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free interval.
    Tomizawa K; Ito S; Suda K; Fukui T; Usami N; Hatooka S; Kuwano H; Yatabe Y; Mitsudomi T
    Lung Cancer; 2013 Apr; 80(1):99-101. PubMed ID: 23279872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma.
    Hong M; Kim RN; Song JY; Choi SJ; Oh E; Lira ME; Mao M; Takeuchi K; Han J; Kim J; Choi YL
    J Thorac Oncol; 2014 Mar; 9(3):419-22. PubMed ID: 24518094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
    Inamura K; Takeuchi K; Togashi Y; Nomura K; Ninomiya H; Okui M; Satoh Y; Okumura S; Nakagawa K; Soda M; Choi YL; Niki T; Mano H; Ishikawa Y
    J Thorac Oncol; 2008 Jan; 3(1):13-7. PubMed ID: 18166835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case report.
    Volckmar AL; Endris V; Bozorgmehr F; Lier C; Porcel C; Kirchner M; Leichsenring J; Penzel R; Thomas M; Schirmacher P; Warth A; Stenzinger A
    Diagn Pathol; 2016 Nov; 11(1):133. PubMed ID: 27863497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitive detection of EML4-ALK fusion oncoprotein of lung cancer by in situ proximity ligation assay.
    Rho JK; Lee H; Park CS; Choi CM; Lee JC
    Clin Chem Lab Med; 2013 Sep; 51(9):1843-8. PubMed ID: 23612660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.